This bill (HD 1365) allows pharmacists in Massachusetts to dispense opioid reversal drugs (like naloxone) without a specific prescription, using a statewide standing order. It directly affects pharmacists, healthcare providers, and individuals at risk of opioid overdose by removing prescription barriers. Key provisions include granting legal immunity to pharmacists and others acting in good faith when dispensing or administering these drugs, requiring annual anonymous reporting of dispensing data, and clarifying insurance billing procedures. The law aims to increase access to life-saving reversal medications during overdose emergencies.
This bill (SD 45) requires the Massachusetts Department of Developmental Services to formally include "fetal opioid drug exposure and addiction" within the existing definition of "Closely Related Developmental Conditions" under state regulations. It directly affects individuals with developmental conditions linked to prenatal opioid exposure by ensuring they qualify for related support services. The key mechanism is amending regulatory definitions to expand eligibility, without creating new programs or funding. The commissioner may also later add other diagnoses to this category at their discretion.
By Mr. Feeney, a petition (accompanied by bill, Senate, No. 1395) of Paul R. Feeney for legislation relative to suicide prevention signage at certain facilities. Mental Health, Substance Use and Recovery.
By Ms. Friedman, a petition (accompanied by bill, Senate, No. 1403) of Cindy F. Friedman, Joanne M. Comerford, Mike Connolly, Adam Gómez and other members of the General Court for legislation relative to reducing administrative burden. Mental Health, Substance Use and Recovery.
By Mr. Collins, a petition (accompanied by bill) (subject to Joint Rule 12) of Nick Collins for legislation relative to discharges from sober homes. Mental Health, Substance Use and Recovery.
This bill (SD 789) requires schools to treat absences due to mental health symptoms the same as absences due to physical health symptoms. It mandates that schools accept documentation from licensed mental health professionals for mental health absences in the same way they accept documentation for physical health absences. Students returning after a mental health-related absence must be offered a meeting with a school counselor, though they cannot be required to attend. The law directly affects students, families, and school staff by standardizing absence policies for mental and physical health.
The bill HD 3449 (An Act relative to discharges from sober homes) is currently a draft being developed by House Counsel, with no substantive text provided in the available context. As a draft, the specific provisions, affected parties, or mechanisms of the bill cannot be summarized at this time. Legislative drafts like this often outline procedures for client discharges from sober living facilities but require finalized text for accurate description. Until the draft is completed and published, concrete details about its policy changes or scope remain unavailable.
This bill establishes a special commission to audit all abandoned state properties and assess whether they could be repurposed as drug addiction treatment facilities. The commission will hold public hearings and submit annual reports by June 30 to the governor and legislature, including feasibility findings and draft legislation for any recommended changes. It directly affects abandoned state properties and the process for evaluating their potential use in addressing substance use disorders. The bill creates a structured review process but does not authorize immediate repurposing or funding for treatment facilities.
HD 4196 establishes a two-year pilot program (starting January 2026) allowing research into psilocybin-assisted therapy for adults aged 21+ with specific conditions like PTSD, end-of-life distress, or depression in designated areas. The program, managed by the Department of Public Health, will partner with universities and community-based providers (such as mental health clinics and hospices) to conduct studies under FDA-approved pathways. Key provisions include developing professional standards, training facilitators, collecting data on efficacy and cost, and reporting annually to legislative committees on statewide impacts and potential MassHealth coverage feasibility. The pilot focuses solely on research in controlled settings, not legalization, with funding covering administration, training, data collection, and community education.
HD 2877 creates the Perinatal Behavioral Health Care Workforce Trust Fund to address shortages in mental health providers specializing in perinatal care (pregnancy through one year post-birth). The fund provides grants to organizations developing training programs for behavioral health professionals serving perinatal individuals, with priority given to programs targeting medically underserved populations or areas with racial, geographic, or health outcome disparities. The Secretary of Health and Human Services must administer the grants, publish annual reports on grant recipients, participant demographics, and program impacts, and ensure funds address workforce shortages. This bill directly affects perinatal individuals (including new parents, adoptive/foster parents, and those experiencing pregnancy loss) in underserved communities by aiming to expand access to specialized mental health care.
